Ovarian cysts in NaProTECHNOLOGY are classified as functional (follicular cysts, luteinized unruptured follicle, corpus luteum cysts) or pathological (endometriomas, neoplasms) through serial cycle-timed transvaginal ultrasound correlated with CrMS Peak day observations and post-Peak progesterone and estradiol profiles. Management of functional cysts uses cooperative progesterone replacement and targeted HCG injections to normalize corpus luteum function and reduce cyst recurrence without contraceptive suppression, while pathological or persistent cysts are addressed through fertility-sparing laparoscopic surgery with anti-adhesion technique.
can ovarian cysts go away without surgery, do birth control pills shrink ovarian cysts, what is a luteinized unruptured follicle, functional ovarian cyst causes and treatment, ovarian cyst identification with fertility charting, how to avoid ovarian cyst surgery, recurrent ovarian cysts hormonal treatment, progesterone for ovarian cyst resolution
Cite this article
Hilgers, T. W. (2004). Chapter 31: Ovarian Cysts: Evaluation and Treatment. The Medical and Surgical Practice of NaProTECHNOLOGY, 381-386.
Hilgers TW. Chapter 31: Ovarian Cysts: Evaluation and Treatment. The Medical and Surgical Practice of NaProTECHNOLOGY. 2004:381-386.
Hilgers, T. W. "Chapter 31: Ovarian Cysts: Evaluation and Treatment." The Medical and Surgical Practice of NaProTECHNOLOGY, 2004, pp. 381-386.
Related articles
NaProTECHNOLOGY biomarkersCreighton Model cycle chartingovulation disorder classificationmucus cycle score and pregnancy outcomes
Thomas W. Hilgers, 2004·The Medical and Surgical Practice of NaProTECHNOLOGY
NaProTECHNOLOGY utilizes a defined panel of cycle-phase-specific biomarkers — including targeted progesterone, estradiol, LH, FSH, and prolactin drawn at CrMS-standardized cycle days — to characterize the hormonal profile underlying each patient's reproductive dysfunction. This biomarker summary consolidates reference ranges, collection timing rules, and clinical interpretation frameworks that govern diagnosis and treatment decisions across infertility, endometriosis, recurrent pregnancy loss, and cycle irregularity.
Hilgers TW, 2004·The Medical and Surgical Practice of NaProTECHNOLOGY
Serial transvaginal ultrasound monitoring of follicular dynamics -- growth, rupture, corpus luteum formation, and free fluid -- forms the basis of a systematic classification of human ovulation disorders, including anovulation, luteinized unruptured follicle (LUF), follicular arrest, premature luteinization, and PCOS-type patterns. Anchoring sonographic findings to the CrMS Peak day allows precise correlation between ultrasound events and cervical mucus biomarkers, creating a reproducible diagnostic taxonomy that drives targeted medical and surgical treatment within the NaProTECHNOLOGY framework.
Fertility AwarenessScientific FoundationsBiophysical Properties and Mucus TypingHormonal and Ultrasound Correlation
Hilgers TW, 2004·The Medical and Surgical Practice of NaProTECHNOLOGY
The CREIGHTON MODEL FertilityCare System (CrMS) rests on a decades-long body of research demonstrating that cervical mucus functions as a physiologically regulated biological valve, opening predictably at the periovulatory estrogen rise and closing in the post-Peak phase. Chapter 15 of Hilgers (2004) synthesizes hormonal, ultrasound, cytologic, and biophysical evidence to establish that a woman's external observation of her Peak Day reliably identifies the fertile window, and documents the system's effectiveness data for both achieving and avoiding pregnancy across a five-study meta-analysis of nearly 1,900 couples.
PCOSEpidemiology and PrevalenceMetabolic ReframeDefective Ovulatory Events
Hilgers TW, 2004·The Medical and Surgical Practice of NaProTECHNOLOGY
PCOS (polycystic ovary syndrome), increasingly designated PMOS (polycystic metabolic ovary syndrome) to reflect its metabolic complexity, is far more prevalent than its classic presentation suggests, affecting roughly six percent of reproductive-age women and carrying systemic consequences well beyond fertility disruption. This chapter from the foundational NaProTECHNOLOGY textbook maps the hormonal architecture of the condition, its ovulatory defect patterns, its frequent co-occurrence with endometriosis, and the restorative surgical and cycle-tracking approaches developed at the Pope Paul VI Institute.